Article
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
Stem cells (Dayton, Ohio) - 1 Oct 2011
Baum Christopher, Modlich Ute, Göhring Gudrun, Schlegelberger Brigitte
Abstract excerpt
The therapeutic use of procedures for genetic stem cell modification is limited by potential adverse events related to uncontrolled mutagenesis. Prominent findings have been made in hematopoietic gene therapy, demonstrating the risk of clonal, potentially malignant outgrowth on the basis of mutations acquired during or after therapeutic genome modification. The incidence and the growth rate of insertional mutants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
